paclitaxel ptx Search Results


94
Gold Biotechnology Inc paclitaxel
Paclitaxel, supplied by Gold Biotechnology Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/paclitaxel+ptx/Paclitaxel%2C+Antibiotic+for+Culture+Media+Use+Only/us12606546-890-3-6
Average 94 stars, based on 1 article reviews
paclitaxel - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

90
Bioarray Inc ptx-og (paclitaxel oregon green
Common label types.
Ptx Og (Paclitaxel Oregon Green, supplied by Bioarray Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/paclitaxel+ptx/ptx+og++paclitaxel+oregon+green/pmc11445045-27-0-6
Average 90 stars, based on 1 article reviews
ptx-og (paclitaxel oregon green - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
LC Laboratories paclitaxel (ptx
Common label types.
Paclitaxel (Ptx, supplied by LC Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/paclitaxel+ptx/paclitaxel+ptx/pmc06466635-58-0-6
Average 90 stars, based on 1 article reviews
paclitaxel (ptx - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Mayne Pharma paclitaxel ptx
WT BALB/c mice (n=5–10/group) were injected s.c. with 5 × 105 TUBO cells and treated with 100 μg of anti-neu antibody (α-neu) on days 11 and 16. Select chemotherapeutic agents were injected i.p. at different time points. One of three experiments is shown. (A) 100 mg/kg of Cyclophosphamide (CTX) was injected i.p. on days 16, 23, and 33. (B) 40 mg/kg of <t>Paclitaxel</t> (PTX) weas injected i.p. on days 14 and 19. Treated, tumor-free mice were re-challenged with 2 × 106 TUBO cells when primary tumor was not detected for at least 30 days. Percent tumor-bearing mice (C) and mean tumor volume (D) are shown. Reduced T cell proliferation was seen in Figure S3.
Paclitaxel Ptx, supplied by Mayne Pharma, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/paclitaxel+ptx/paclitaxel++ptx/pmc02923645-413-12-14
Average 90 stars, based on 1 article reviews
paclitaxel ptx - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Bristol Myers paclitaxel ptx
WT BALB/c mice (n=5–10/group) were injected s.c. with 5 × 105 TUBO cells and treated with 100 μg of anti-neu antibody (α-neu) on days 11 and 16. Select chemotherapeutic agents were injected i.p. at different time points. One of three experiments is shown. (A) 100 mg/kg of Cyclophosphamide (CTX) was injected i.p. on days 16, 23, and 33. (B) 40 mg/kg of <t>Paclitaxel</t> (PTX) weas injected i.p. on days 14 and 19. Treated, tumor-free mice were re-challenged with 2 × 106 TUBO cells when primary tumor was not detected for at least 30 days. Percent tumor-bearing mice (C) and mean tumor volume (D) are shown. Reduced T cell proliferation was seen in Figure S3.
Paclitaxel Ptx, supplied by Bristol Myers, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/paclitaxel+ptx/paclitaxel+ptx/pm25017716-33-0-5
Average 90 stars, based on 1 article reviews
paclitaxel ptx - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Tokyo Chemical Industry paclitaxel (ptx)
WT BALB/c mice (n=5–10/group) were injected s.c. with 5 × 105 TUBO cells and treated with 100 μg of anti-neu antibody (α-neu) on days 11 and 16. Select chemotherapeutic agents were injected i.p. at different time points. One of three experiments is shown. (A) 100 mg/kg of Cyclophosphamide (CTX) was injected i.p. on days 16, 23, and 33. (B) 40 mg/kg of <t>Paclitaxel</t> (PTX) weas injected i.p. on days 14 and 19. Treated, tumor-free mice were re-challenged with 2 × 106 TUBO cells when primary tumor was not detected for at least 30 days. Percent tumor-bearing mice (C) and mean tumor volume (D) are shown. Reduced T cell proliferation was seen in Figure S3.
Paclitaxel (Ptx), supplied by Tokyo Chemical Industry, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/paclitaxel+ptx/paclitaxel+ptx/pm36406225-161-18-6
Average 90 stars, based on 1 article reviews
paclitaxel (ptx) - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Polymed Therapeutics paclitaxel (ptx) powder
WT BALB/c mice (n=5–10/group) were injected s.c. with 5 × 105 TUBO cells and treated with 100 μg of anti-neu antibody (α-neu) on days 11 and 16. Select chemotherapeutic agents were injected i.p. at different time points. One of three experiments is shown. (A) 100 mg/kg of Cyclophosphamide (CTX) was injected i.p. on days 16, 23, and 33. (B) 40 mg/kg of <t>Paclitaxel</t> (PTX) weas injected i.p. on days 14 and 19. Treated, tumor-free mice were re-challenged with 2 × 106 TUBO cells when primary tumor was not detected for at least 30 days. Percent tumor-bearing mice (C) and mean tumor volume (D) are shown. Reduced T cell proliferation was seen in Figure S3.
Paclitaxel (Ptx) Powder, supplied by Polymed Therapeutics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/paclitaxel+ptx/paclitaxel++ptx++powder/us09186410-738-0-6
Average 90 stars, based on 1 article reviews
paclitaxel (ptx) powder - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
LC Laboratories paclitaxel (ptx, > 99.5
In vivo efficacy of HPMA copolymer–drug conjugates against A2780 human ovarian tumor xenografts. Tumor cells (5 × 106/mouse) were inoculated subcutaneously on the back, and administration started when the tumor size reached ~100–200 mm3 (n = 5). As a comparison, sequential combination therapy of 2P–PTX followed by 2P–GEM was also plotted in both cases. (A) Tumor growth was inhibited by gemcitabine monotherapy. Intravenous injection three times with a 7-day interval. (B) Tumor growth was inhibited by <t>paclitaxel</t> monotherapy with a single intravenous administration on day. The dose of conjugate for each injection is expressed as a dose equivalent to free drug gemcitabine (5 mg/kg) or paclitaxel (20 mg/kg).
Paclitaxel (Ptx, > 99.5, supplied by LC Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/paclitaxel+ptx/paclitaxel++ptx+++99+5++purity/pmc08494043-90-0-7
Average 90 stars, based on 1 article reviews
paclitaxel (ptx, > 99.5 - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Shanghai Xudong Haipu Pharmaceutical Co Ltd paclitaxel ptx
In vivo efficacy of HPMA copolymer–drug conjugates against A2780 human ovarian tumor xenografts. Tumor cells (5 × 106/mouse) were inoculated subcutaneously on the back, and administration started when the tumor size reached ~100–200 mm3 (n = 5). As a comparison, sequential combination therapy of 2P–PTX followed by 2P–GEM was also plotted in both cases. (A) Tumor growth was inhibited by gemcitabine monotherapy. Intravenous injection three times with a 7-day interval. (B) Tumor growth was inhibited by <t>paclitaxel</t> monotherapy with a single intravenous administration on day. The dose of conjugate for each injection is expressed as a dose equivalent to free drug gemcitabine (5 mg/kg) or paclitaxel (20 mg/kg).
Paclitaxel Ptx, supplied by Shanghai Xudong Haipu Pharmaceutical Co Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/paclitaxel+ptx/paclitaxel+ptx/10__5897_slash_ajb11__3347-46-0-15
Average 90 stars, based on 1 article reviews
paclitaxel ptx - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Shanghai Acmec Biochemical Technology Co Ltd paclitaxel ptx
In vivo efficacy of HPMA copolymer–drug conjugates against A2780 human ovarian tumor xenografts. Tumor cells (5 × 106/mouse) were inoculated subcutaneously on the back, and administration started when the tumor size reached ~100–200 mm3 (n = 5). As a comparison, sequential combination therapy of 2P–PTX followed by 2P–GEM was also plotted in both cases. (A) Tumor growth was inhibited by gemcitabine monotherapy. Intravenous injection three times with a 7-day interval. (B) Tumor growth was inhibited by <t>paclitaxel</t> monotherapy with a single intravenous administration on day. The dose of conjugate for each injection is expressed as a dose equivalent to free drug gemcitabine (5 mg/kg) or paclitaxel (20 mg/kg).
Paclitaxel Ptx, supplied by Shanghai Acmec Biochemical Technology Co Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/paclitaxel+ptx/paclitaxel+ptx/pm36770692-95-0-9
Average 90 stars, based on 1 article reviews
paclitaxel ptx - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Pharmachemicals Inc paclitaxel reference standard (99% purity)
Concentration of <t>paclitaxel</t> in the diaphragm over time. Paclitaxel (3 mg/kg) was administered by either intravenous IV (solid line) or intrapleural (IP) (dotted line) injection. Approximately 100 mg of tissue from the diaphragm was harvested from six rats in each group at the time points indicated. The concentration of paclitaxel was determined by liquid chromatography-tandem mass spectrometry (LC-MS/MS). The mean ± standard deviation (SD) is shown for each time point. , IV; , IP.
Paclitaxel Reference Standard (99% Purity), supplied by Pharmachemicals Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/paclitaxel+ptx/paclitaxel+ptx/pmc04448465-46-1-10
Average 90 stars, based on 1 article reviews
paclitaxel reference standard (99% purity) - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
ImmunoGen Inc paclitaxel-poly(l-lysine) conjugate ptx–pll
Concentration of <t>paclitaxel</t> in the diaphragm over time. Paclitaxel (3 mg/kg) was administered by either intravenous IV (solid line) or intrapleural (IP) (dotted line) injection. Approximately 100 mg of tissue from the diaphragm was harvested from six rats in each group at the time points indicated. The concentration of paclitaxel was determined by liquid chromatography-tandem mass spectrometry (LC-MS/MS). The mean ± standard deviation (SD) is shown for each time point. , IV; , IP.
Paclitaxel Poly(l Lysine) Conjugate Ptx–Pll, supplied by ImmunoGen Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/paclitaxel+ptx/paclitaxel+poly+l+lysine++conjugate+ptx+pll/pmc10908151-158-5-8
Average 90 stars, based on 1 article reviews
paclitaxel-poly(l-lysine) conjugate ptx–pll - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

Image Search Results


Common label types.

Journal: Frontiers in Bioengineering and Biotechnology

Article Title: Factors to consider before choosing EV labeling method for fluorescence-based techniques

doi: 10.3389/fbioe.2024.1479516

Figure Lengend Snippet: Common label types.

Article Snippet: Ptx-OG (paclitaxel Oregon Green) , Creative Bioarray , fluorescent dye conjugate of the chemotherapy drug paclitaxel , selective labeling, minimal interference, high fluorescence quantum yield, photostability , potential for nonspecific binding, paclitaxel cytotoxicity , may impact EV protein function and sorting , EV uptake and intracellular trafficking , .

Techniques: Staining, Membrane, Labeling, Live Cell Imaging, Binding Assay, Functional Assay, In Vitro, Fluorescence, Imaging, In Vivo, In Vivo Imaging, Solubility, Concentration Assay, Liposomes, Microscopy, Flow Cytometry, Permeability, Modification, Disruption, Avidin-Biotin Assay, Isolation, Expressing

WT BALB/c mice (n=5–10/group) were injected s.c. with 5 × 105 TUBO cells and treated with 100 μg of anti-neu antibody (α-neu) on days 11 and 16. Select chemotherapeutic agents were injected i.p. at different time points. One of three experiments is shown. (A) 100 mg/kg of Cyclophosphamide (CTX) was injected i.p. on days 16, 23, and 33. (B) 40 mg/kg of Paclitaxel (PTX) weas injected i.p. on days 14 and 19. Treated, tumor-free mice were re-challenged with 2 × 106 TUBO cells when primary tumor was not detected for at least 30 days. Percent tumor-bearing mice (C) and mean tumor volume (D) are shown. Reduced T cell proliferation was seen in Figure S3.

Journal:

Article Title: The Therapeutic Effect of Anti-HER2/neu Antibody Depends on Both Innate and Adaptive Immunity

doi: 10.1016/j.ccr.2010.06.014

Figure Lengend Snippet: WT BALB/c mice (n=5–10/group) were injected s.c. with 5 × 105 TUBO cells and treated with 100 μg of anti-neu antibody (α-neu) on days 11 and 16. Select chemotherapeutic agents were injected i.p. at different time points. One of three experiments is shown. (A) 100 mg/kg of Cyclophosphamide (CTX) was injected i.p. on days 16, 23, and 33. (B) 40 mg/kg of Paclitaxel (PTX) weas injected i.p. on days 14 and 19. Treated, tumor-free mice were re-challenged with 2 × 106 TUBO cells when primary tumor was not detected for at least 30 days. Percent tumor-bearing mice (C) and mean tumor volume (D) are shown. Reduced T cell proliferation was seen in Figure S3.

Article Snippet: Chemotherapeutic agents; erlotinib (Tarceva TM , Genentech, CA), cyclophosphamide (CTX, Baxter, IL), paclitaxel (PTX, Mayne Pharma Inc. NJ), and doxorubicin (DOX, Teva Parenteral Medicine, CA) were purchased and prepared according to the Manufacturers’ recommendations.

Techniques: Injection

In vivo efficacy of HPMA copolymer–drug conjugates against A2780 human ovarian tumor xenografts. Tumor cells (5 × 106/mouse) were inoculated subcutaneously on the back, and administration started when the tumor size reached ~100–200 mm3 (n = 5). As a comparison, sequential combination therapy of 2P–PTX followed by 2P–GEM was also plotted in both cases. (A) Tumor growth was inhibited by gemcitabine monotherapy. Intravenous injection three times with a 7-day interval. (B) Tumor growth was inhibited by paclitaxel monotherapy with a single intravenous administration on day. The dose of conjugate for each injection is expressed as a dose equivalent to free drug gemcitabine (5 mg/kg) or paclitaxel (20 mg/kg).

Journal: Molecular pharmaceutics

Article Title: Backbone Degradable N -(2-Hydroxypropyl)methacrylamide Copolymer Conjugates with Gemcitabine and Paclitaxel: Impact of Molecular Weight on Activity toward Human Ovarian Carcinoma Xenografts

doi: 10.1021/acs.molpharmaceut.6b01005

Figure Lengend Snippet: In vivo efficacy of HPMA copolymer–drug conjugates against A2780 human ovarian tumor xenografts. Tumor cells (5 × 106/mouse) were inoculated subcutaneously on the back, and administration started when the tumor size reached ~100–200 mm3 (n = 5). As a comparison, sequential combination therapy of 2P–PTX followed by 2P–GEM was also plotted in both cases. (A) Tumor growth was inhibited by gemcitabine monotherapy. Intravenous injection three times with a 7-day interval. (B) Tumor growth was inhibited by paclitaxel monotherapy with a single intravenous administration on day. The dose of conjugate for each injection is expressed as a dose equivalent to free drug gemcitabine (5 mg/kg) or paclitaxel (20 mg/kg).

Article Snippet: Paclitaxel (PTX, > 99.5%) was purchased from LC Laboratories (Woburn, MA).

Techniques: In Vivo, Injection

(A) In vivo efficacy of degradable diblock copolymer–GEM conjugates and PTX conjugates against A2780 human ovarian tumor xenografts. Tumor cells (5 × 106/mouse) were inoculated subcutaneously on the back of nude mice, and administration started when the tumor size reached ~100–200 mm3 (n = 5). Tumor growth was inhibited by either monotherapy or combination therapy. Intravenous and intraperitoneal injections were conducted, respectively. The doses of conjugates (gemcitabine 5 mg/kg × 3 on days 0, 7, 14 and paclitaxel 20 mg/kg on day 0) are in drug equivalent. (B) Body-weight change.

Journal: Molecular pharmaceutics

Article Title: Backbone Degradable N -(2-Hydroxypropyl)methacrylamide Copolymer Conjugates with Gemcitabine and Paclitaxel: Impact of Molecular Weight on Activity toward Human Ovarian Carcinoma Xenografts

doi: 10.1021/acs.molpharmaceut.6b01005

Figure Lengend Snippet: (A) In vivo efficacy of degradable diblock copolymer–GEM conjugates and PTX conjugates against A2780 human ovarian tumor xenografts. Tumor cells (5 × 106/mouse) were inoculated subcutaneously on the back of nude mice, and administration started when the tumor size reached ~100–200 mm3 (n = 5). Tumor growth was inhibited by either monotherapy or combination therapy. Intravenous and intraperitoneal injections were conducted, respectively. The doses of conjugates (gemcitabine 5 mg/kg × 3 on days 0, 7, 14 and paclitaxel 20 mg/kg on day 0) are in drug equivalent. (B) Body-weight change.

Article Snippet: Paclitaxel (PTX, > 99.5%) was purchased from LC Laboratories (Woburn, MA).

Techniques: In Vivo

Concentration of paclitaxel in the diaphragm over time. Paclitaxel (3 mg/kg) was administered by either intravenous IV (solid line) or intrapleural (IP) (dotted line) injection. Approximately 100 mg of tissue from the diaphragm was harvested from six rats in each group at the time points indicated. The concentration of paclitaxel was determined by liquid chromatography-tandem mass spectrometry (LC-MS/MS). The mean ± standard deviation (SD) is shown for each time point. , IV; , IP.

Journal: Thoracic Cancer

Article Title: Pharmacokinetic profile of paclitaxel in the plasma, lung, and diaphragm following intravenous or intrapleural administration in rats

doi: 10.1111/1759-7714.12139

Figure Lengend Snippet: Concentration of paclitaxel in the diaphragm over time. Paclitaxel (3 mg/kg) was administered by either intravenous IV (solid line) or intrapleural (IP) (dotted line) injection. Approximately 100 mg of tissue from the diaphragm was harvested from six rats in each group at the time points indicated. The concentration of paclitaxel was determined by liquid chromatography-tandem mass spectrometry (LC-MS/MS). The mean ± standard deviation (SD) is shown for each time point. , IV; , IP.

Article Snippet: The paclitaxel reference standard (99% purity) was obtained from Knowshine Pharmachemicals Inc. (Shanghai, China, Lot No. LX-P-902-0904006).

Techniques: Concentration Assay, Injection, Liquid Chromatography, Mass Spectrometry, Liquid Chromatography with Mass Spectroscopy, Standard Deviation

Concentration of paclitaxel in the lung over time. Paclitaxel (3 mg/kg) was administered by either intravenous (IV) (solid line) or intrapleural (IP) (dotted line) injection. Approximately 100 mg of lung tissue was harvested from six rats in each group at the time points indicated. The concentration of paclitaxel was determined by liquid chromatography-tandem mass spectrometry (LC-MS/MS). The mean ± standard deviation (SD) is shown for each time point. , IV; , IP.

Journal: Thoracic Cancer

Article Title: Pharmacokinetic profile of paclitaxel in the plasma, lung, and diaphragm following intravenous or intrapleural administration in rats

doi: 10.1111/1759-7714.12139

Figure Lengend Snippet: Concentration of paclitaxel in the lung over time. Paclitaxel (3 mg/kg) was administered by either intravenous (IV) (solid line) or intrapleural (IP) (dotted line) injection. Approximately 100 mg of lung tissue was harvested from six rats in each group at the time points indicated. The concentration of paclitaxel was determined by liquid chromatography-tandem mass spectrometry (LC-MS/MS). The mean ± standard deviation (SD) is shown for each time point. , IV; , IP.

Article Snippet: The paclitaxel reference standard (99% purity) was obtained from Knowshine Pharmachemicals Inc. (Shanghai, China, Lot No. LX-P-902-0904006).

Techniques: Concentration Assay, Injection, Liquid Chromatography, Mass Spectrometry, Liquid Chromatography with Mass Spectroscopy, Standard Deviation